Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cord for Life, Inc.
WARNING LETTER
•Cord for Life, Inc.•November 30, 2018

Cord for Life, Inc. – FDA Warning Letter, Nov 30, 2018

Record Details

On March 29, 2019, the FDA issued a Warning Letter to Cord for Life, Inc. following an inspection from November 26-30, 2018. The inspection revealed that the firm's human umbilical cord blood products (PremierMaxCB Platinum, Gold, and Silver), marketed for "therapeutic uses" like orthopedic conditions, are considered unapproved drugs and biological products under the FD&C Act and PHS Act. They do not qualify for HCT/P exceptions as they are not for homologous use and are dependent on metabolic activity of living cells for their primary function, without being for autologous, related allogeneic, or reproductive use.

The firm lacks an approved biologics license or an Investigational New Drug (IND) application. Additionally, significant Current Good Manufacturing Practice (CGMP) deviations were observed, posing potential safety concerns due to unvalidated processes, uncontrolled environments, and inadequate aseptic practices. Deficiencies include failure to prevent microbiological contamination (e.g., unvalidated aseptic process, poor personnel practices, positive microbial samples without investigation), inadequate environmental monitoring (e.g., infrequent monitoring, non-representative samples, lack of alert/action limits), unvalidated cleaning procedures for equipment, unvalidated manufacturing processes, and insufficient laboratory controls (e.g., no specifications for identity, strength, quality, purity; inadequate sterility testing). The firm also assigns a three-year expiration date without supporting stability data.

The FDA

Company
Cord for Life, Inc.
Inspection date
November 30, 2018
Product type
Biologics
Office
Division of Biological Products Operations I
People
  • Elizabeth A. Waltrip (Program Division Director)
  • Daniel W. Cline
View Company Profile

ID · 72664f21-c309-4ba3-9b10-d453c3ec07db

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 CFR 1271.3(d)21 CFR 1271.10(a)21 CFR 1271.1521 CFR 1271.10(a)(2)21 CFR 1271.3(c)21 CFR 1271.10(a)(4)21 U.S.C. 355(i)42 U.S.C. 262(i)

Full citation text and observation details available on the Dashboard.

Other documents for Cord for Life, Inc.
  • 483 - 2026-06-10June 10, 2026
  • 483 - 2021-08-26August 26, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cord for Life, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.